Bridgecreek Investment Management LLC increased its position in Clorox Company (The) (NYSE:CLX) by 1.2% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 42,625 shares of the company’s stock after purchasing an additional 500 shares during the quarter. Clorox Company (The) makes up about 1.5% of Bridgecreek Investment Management LLC’s investment portfolio, making the stock its 27th largest holding. Bridgecreek Investment Management LLC’s holdings in Clorox Company (The) were worth $5,623,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in CLX. Janus Henderson Group PLC lifted its stake in shares of Clorox Company (The) by 8,008.5% in the 2nd quarter. Janus Henderson Group PLC now owns 1,323,475 shares of the company’s stock valued at $176,340,000 after purchasing an additional 1,307,153 shares during the period. Vanguard Group Inc. lifted its stake in shares of Clorox Company (The) by 2.6% in the 2nd quarter. Vanguard Group Inc. now owns 14,534,634 shares of the company’s stock valued at $1,936,595,000 after purchasing an additional 369,918 shares during the period. APG Asset Management N.V. lifted its stake in shares of Clorox Company (The) by 30.9% in the 3rd quarter. APG Asset Management N.V. now owns 1,301,915 shares of the company’s stock valued at $171,736,000 after purchasing an additional 307,700 shares during the period. Ameriprise Financial Inc. raised its stake in Clorox Company (The) by 24.6% during the second quarter. Ameriprise Financial Inc. now owns 1,341,272 shares of the company’s stock valued at $178,433,000 after buying an additional 265,200 shares during the last quarter. Finally, Renaissance Technologies LLC raised its stake in Clorox Company (The) by 24.5% during the second quarter. Renaissance Technologies LLC now owns 1,341,400 shares of the company’s stock valued at $178,728,000 after buying an additional 263,700 shares during the last quarter. Institutional investors own 71.58% of the company’s stock.

In other news, COO Dawn C. Willoughby sold 2,158 shares of the business’s stock in a transaction dated Tuesday, August 29th. The stock was sold at an average price of $138.00, for a total value of $297,804.00. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, SVP Jon M. Balousek sold 9,223 shares of the business’s stock in a transaction dated Wednesday, August 23rd. The shares were sold at an average price of $138.87, for a total value of $1,280,798.01. Following the completion of the transaction, the senior vice president now owns 20,614 shares in the company, valued at $2,862,666.18. The disclosure for this sale can be found here. Insiders sold 41,293 shares of company stock worth $5,560,303 over the last 90 days. Company insiders own 1.00% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This news story was first posted by Daily Political and is the sole property of of Daily Political. If you are viewing this news story on another website, it was copied illegally and reposted in violation of US & international trademark and copyright law. The correct version of this news story can be accessed at https://www.dailypolitical.com/2017/11/13/clorox-company-the-clx-shares-bought-by-bridgecreek-investment-management-llc.html.

A number of brokerages have issued reports on CLX. Jefferies Group LLC reiterated a “hold” rating and set a $137.00 price objective (up previously from $136.00) on shares of Clorox Company (The) in a research note on Wednesday, August 9th. Morgan Stanley lowered their price objective on Clorox Company (The) from $138.00 to $128.00 and set an “equal weight” rating for the company in a research note on Thursday, November 2nd. Zacks Investment Research upgraded Clorox Company (The) from a “sell” rating to a “hold” rating in a research note on Monday, November 6th. Royal Bank Of Canada reiterated a “hold” rating and set a $115.00 price objective on shares of Clorox Company (The) in a research note on Wednesday, August 2nd. Finally, Consumer Edge upgraded Clorox Company (The) from a “neutral” rating to an “outperform” rating in a research note on Friday. Two analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have given a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average target price of $128.72.

Clorox Company (NYSE CLX) traded up $1.37 during midday trading on Monday, reaching $132.05. The company had a trading volume of 718,800 shares, compared to its average volume of 815,927. The stock has a market capitalization of $17,200.00, a P/E ratio of 23.79, a PEG ratio of 3.60 and a beta of 0.39. The company has a quick ratio of 0.77, a current ratio of 1.10 and a debt-to-equity ratio of 3.02. Clorox Company has a 12 month low of $111.77 and a 12 month high of $141.76.

Clorox Company (The) (NYSE:CLX) last announced its quarterly earnings data on Wednesday, November 1st. The company reported $1.46 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.41 by $0.05. Clorox Company (The) had a return on equity of 161.59% and a net margin of 11.84%. The business had revenue of $1.50 billion for the quarter, compared to the consensus estimate of $1.48 billion. During the same period in the previous year, the business earned $1.36 earnings per share. The business’s revenue was up 4.0% on a year-over-year basis. sell-side analysts anticipate that Clorox Company will post 5.58 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, November 13th. Stockholders of record on Wednesday, October 25th will be given a $0.84 dividend. The ex-dividend date is Tuesday, October 24th. This represents a $3.36 annualized dividend and a dividend yield of 2.54%. Clorox Company (The)’s payout ratio is 61.65%.

About Clorox Company (The)

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Company (The) (NYSE:CLX).

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.